Fibronostics

Fibronostics is a healthcare technology company that provides algorithm-based solutions in various diagnostic testing fields, focusing on evaluating the presence or progression of liver diseases and other chronic conditions such as coronary heart disease, stroke, diabetes, and obstructive sleep apnea.Fibronostics' main products include:LIVERFASt™, a blood-based diagnostic test that combines 10 biomarkers and algorithmic technology to determine the stage of liver fibrosis activity and steatosis.LIVERFACt, a component of LIVERFASt™, which uses only 6 out of the 10 biomarkers to provide results on the stages of liver fibrosis and activity. LIVERFACt can be used for early diagnosis of liver disease in patients with hepatitis B and hepatitis C.SteatoTEST, which applies similar 10 biomarkers utilized by LIVERFASt™ and provides results for staging hepatic steatosis or fatty liver.LIVERFASt select, a risk stratification tool for fatty liver disease that combines basic blood biomarkers with algorithmic technology.